| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/14/2007 | WO2007067663A1 Use of adsorbent carbon microspheres for the treatment of irritable bowel syndrome |
| 06/14/2007 | WO2007067561A2 Porous calcium phosphate bone material |
| 06/14/2007 | WO2007067520A2 Lipid-based compositions of antiinfectives for treating pulmonary infections |
| 06/14/2007 | WO2007067508A2 Pharmaceutical formulation containing phenytoin sodium and magnesium stearate |
| 06/14/2007 | WO2007067494A1 Topical film compositions for delivery of actives |
| 06/14/2007 | WO2007067470A2 Benzimidazole non-aqueous compositions |
| 06/14/2007 | WO2007067208A1 Aqueous dispersions and solutions of difficult to dissolve compounds and methods of their preparation |
| 06/14/2007 | WO2007067184A1 Orally administrable extended release pellet and tablet formulations of a highly water soluble compound |
| 06/14/2007 | WO2007066889A1 Compositions for external application, containing adenosyl cobalamin for improvement of skin diseases |
| 06/14/2007 | WO2007066832A1 Emulsified composition |
| 06/14/2007 | WO2007066781A1 Process for producing pharmaceutical composition containing drug-encapsulating polymer micelle using fluorine-containing organic solvent |
| 06/14/2007 | WO2007066773A1 Isohumulone compound clathrate and composition containing the same |
| 06/14/2007 | WO2007066678A1 Therapeutic agent for corneal/conjuctival disease |
| 06/14/2007 | WO2007066646A1 Process for producing tablet by high-speed direct compression |
| 06/14/2007 | WO2007066178A2 Capsules or microcapsules with stable outer hydrophilic layer for rapid buccal disintegration |
| 06/14/2007 | WO2007066151A2 Topical compositions for treatment of respiratory disorders |
| 06/14/2007 | WO2007066150A2 Transdermal administration of active agents for systemic effect |
| 06/14/2007 | WO2007066149A2 Topical pharmaceutical compositions |
| 06/14/2007 | WO2007066148A1 Transdermal administration of active agents , in particular diclofenac |
| 06/14/2007 | WO2007066147A1 Topical compositions for paediatric use |
| 06/14/2007 | WO2007065862A1 Process for the perparation of lyophilized piperacilline sodium with improved stability after reconstitution |
| 06/14/2007 | WO2007065619A2 Foam wafer containing a polyvinyl alcohol-polyethyleneglycol-graft copolymer |
| 06/14/2007 | WO2007065588A1 Pharmaceutical compositions comprising cyclosporin |
| 06/14/2007 | WO2007065559A1 Zolpidem tablets |
| 06/14/2007 | WO2007065450A1 Means for preventing and treating conjunctivitis of different ethiology (variants) and a method for the use thereof |
| 06/14/2007 | WO2007065448A1 Stable solid formulation of sertindole |
| 06/14/2007 | WO2007065441A1 Film-coated and/or granulated calcium-containing compounds and use thereof in pharmaceutical compositions |
| 06/14/2007 | WO2007065440A1 Pre-compacted calcium-containing compositions |
| 06/14/2007 | WO2007065428A1 Low flexural strength transdermal tobacco alkaloid patch |
| 06/14/2007 | WO2007065427A1 Transdermal tobacco alkaloid patch |
| 06/14/2007 | WO2007065376A1 Use of cortex prunus armeniaca l. and extracts thereof in manufacturing medicaments for treating cancerous pain |
| 06/14/2007 | WO2007065375A1 Use of apricot bark and extracts thereof in manufacturing medicaments for treating cancer |
| 06/14/2007 | WO2007065374A1 Use of apricot bark and extracts thereof in manufacturing medicaments for promoting immunity |
| 06/14/2007 | WO2007065373A1 Use of cortex prunus armeniaca l. and extracts thereof in manufacturing medicaments for treating diabetes |
| 06/14/2007 | WO2007065372A1 Use of cortex prunus armeniaca l. and extracts thereof in manufacturing medicaments for treating acquired immunodeficiency syndrome |
| 06/14/2007 | WO2007065314A1 Compound preparation for treating virus hepatopathy |
| 06/14/2007 | WO2007065303A1 Transdermal patch containing isosorbide dinitrate and bisoprolol |
| 06/14/2007 | WO2007048223A3 A gastric retention drug delivery system |
| 06/14/2007 | WO2007048046A9 Sirna silencing of filovirus gene expression |
| 06/14/2007 | WO2007046719A3 Encapsulation system |
| 06/14/2007 | WO2007045212A3 Antiviral lip plaster |
| 06/14/2007 | WO2007039294A3 Gelling compositions and methods |
| 06/14/2007 | WO2007035448A3 Highly concentrated pourable aqueous solutions of potassium ibuprofen their preparation and their uses |
| 06/14/2007 | WO2007035313A3 Sachet formulation for amine polymers |
| 06/14/2007 | WO2007026028A3 Pharmaceutical composition comprising an iron chelator |
| 06/14/2007 | WO2007022255A3 Pharmaceutical formulations for sustained release |
| 06/14/2007 | WO2007019845B1 Method for encapsulating therapeutic substances in cells |
| 06/14/2007 | WO2007017901A3 Silver nanoparticle dispersion formulation |
| 06/14/2007 | WO2007015171A3 Method of treating patients with a mucinous glycoprotein (muc-1) vaccine |
| 06/14/2007 | WO2007012981A3 Gellan seamless breakable capsule and process for manufacturing thereof |
| 06/14/2007 | WO2007012962A3 Sono-active liposomes and lipid particles and use thereof as contrast agents and active-agent delivery systems |
| 06/14/2007 | WO2007008300A3 Triblock copolymers for cytoplasmic delivery of gene-based drugs |
| 06/14/2007 | WO2007002872A3 Semi-permeable compositions providing reduced drying time for osmotic dosage forms |
| 06/14/2007 | WO2006135689A3 Nanoparticulate ebastine formulations |
| 06/14/2007 | WO2006127637A3 Compressed pharmaceutical composition comprising coated pellets and a direct compression mixture, and method of preparation thereof |
| 06/14/2007 | WO2006124446A3 Sustained release microparticles for pulmonary delivery |
| 06/14/2007 | WO2006119779A3 A pharmaceutical composition comprising an aldosterone antagonist in form of solid solution |
| 06/14/2007 | WO2006073437A3 Photovoltaic thin-film cell produced from metallic blend using high-temperature printing |
| 06/14/2007 | WO2006034467A3 Biocompatible hydrogel compositions |
| 06/14/2007 | WO2006004736A3 Stable liquid and lyophilized formulation of proteins |
| 06/14/2007 | WO2005115414A3 Orally-administrable compositions comprising stable amorphous calcium carbonate |
| 06/14/2007 | WO2004049904A3 Bioactive, resorbable scaffolds for tissue engineering |
| 06/14/2007 | US20070135801 Osmotic pump with remotely controlled osmotic pressure generation |
| 06/14/2007 | US20070135800 Method and system for control of osmotic pump device |
| 06/14/2007 | US20070135799 Osmotic pump with remotely controlled osmotic pressure generation |
| 06/14/2007 | US20070135798 Remote control of osmotic pump device |
| 06/14/2007 | US20070135797 Osmotic pump with remotely controlled osmotic flow rate |
| 06/14/2007 | US20070135796 Method and apparatus for applying medication to internal tissue |
| 06/14/2007 | US20070135789 Use of mechanical dilator devices to enlarge ostia of paranasal sinuses and other passages in the ear, nose, throat and paranasal sinuses |
| 06/14/2007 | US20070135774 Fluid delivery devices, systems and methods |
| 06/14/2007 | US20070135651 Polymer-stabilised, crystallised, catanionic membranes, preparation method thereof and applications of same |
| 06/14/2007 | US20070135412 Compounds for the treatment of ocular dryness caused by photorefractive surgery |
| 06/14/2007 | US20070135379 Anhydrous pharmaceutical composition associating a siliconated agent and solubilised active principle |
| 06/14/2007 | US20070135370 siRNA molecule for silencing Ebola virus L-polymerase (L-pol) expression; nucleic acid-lipid particles suitable for use in intravenous nucleic acid delivery as they are stable in circulation, of a size required for pharmacodynamic behavior resulting in access to extravascular sites, and target cell |
| 06/14/2007 | US20070134763 Anti-virus therapy for respiratory diseases |
| 06/14/2007 | US20070134344 Antibiotic compositions |
| 06/14/2007 | US20070134343 surgical injection of dehydrated particles or a gel or suspension into the joint; mixtures may also include radiocontrast materials, analgesics, antibiotics, proteoglycans, growth factors, and other cells to promote healing and proper joint function |
| 06/14/2007 | US20070134342 Injectable carrier formulations of hyaluronic acid derivatives for delivery of osteogenic proteins |
| 06/14/2007 | US20070134341 Compositions of lipoxygenase inhibitors |
| 06/14/2007 | US20070134340 Method for delivering hydrophobic drugs via nanocrystal formulations |
| 06/14/2007 | US20070134339 Zonisamide and nsaid nanoparticulate formulations |
| 06/14/2007 | US20070134338 Methods for producing nanoparticulate metal complexes and altering nanoparticle morphology |
| 06/14/2007 | US20070134337 Bacteria binding products |
| 06/14/2007 | US20070134336 Method for improving the properties of amphiphile particles |
| 06/14/2007 | US20070134335 Polypeptides with the capacity to entrap drugs and release them in a controlled way |
| 06/14/2007 | US20070134334 Crosslinked polysaccharide microparticles and method for their preparation |
| 06/14/2007 | US20070134332 Polymer particles for delivery of macromolecules and methods of use |
| 06/14/2007 | US20070134331 Orodispersible pharmaceutical composition for oromucosal or sublingual administration of agomelatine |
| 06/14/2007 | US20070134330 Methods and compositions for improved image quality |
| 06/14/2007 | US20070134329 Multi-particulate oral dosage form |
| 06/14/2007 | US20070134328 Oxymorphone controlled release formulations |
| 06/14/2007 | US20070134327 Compositions and methods for improved efficacy of penicillin-type antibiotics |
| 06/14/2007 | US20070134326 Composition for releasing a weak base for an extended period of time |
| 06/14/2007 | US20070134325 Beta-lactam antibiotic-containing tablet and production thereof |
| 06/14/2007 | US20070134324 Therapeutic combinations |
| 06/14/2007 | US20070134323 Ziprasidone suspension |
| 06/14/2007 | US20070134322 Modified and pulsatile release pharmaceutical formulations of escitalopram |
| 06/14/2007 | US20070134321 Immediate-release; allows a single drug or a mixture of two drugs to be accurately divided in halves with regard to the dose, even if the tablet does not break into equal halves by mass; warfarin, a statin, risperidone, methotrexate, metformin, atenolol, prednisone, phenytoin, lamotrigine, meloxicam |
| 06/14/2007 | US20070134320 orally ingested composition for treatment of herpetic epidermal lesions caused by Herpes Simplex Virus, Herpes Zoster, and Herpes Genitalia, consisting of zinc sulfate, magnesium sulfate, thiamine, riboflavin, pyridoxine hydrochloride, ascorbic acid, niacin, pantothenic acid, in tablets or capsules |
| 06/14/2007 | US20070134319 Pharmaceutical formulations of bisphosphonates |